Literature DB >> 12510154

Upregulation of survivin by HIV-1 Vpr.

Y Zhu1, M Roshal, F Li, J Blackett, V Planelles.   

Abstract

The human survivin gene belongs to the family of inhibitor of apoptosis proteins (IAP) and is involved in apoptosis inhibition and regulation of cell division. The survivin gene is the only member of the IAP family whose expression is known to be regulated through the cell cycle. Survivin expression reaches the highest levels during the G(2)/M transition and then is rapidly degraded during the G(1) phase. Here we report that the human immunodeficiency virus type 1 (HIV-1) upregulates Survivin expression via survivin promoter transactivation. Vpr, an HIV-1 accessory protein that induces cell cycle arrest in G(2)/M, is necessary and sufficient for this effect. Blocking Vpr-induced G(2)/M arrest leads to elimination of the survivin promoter transactivation by Vpr. Our results suggest that Survivin may be actively involved in regulating cell viability during HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12510154     DOI: 10.1023/a:1021653119934

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  23 in total

1.  Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin.

Authors:  Jie Lu; Masanao Murakami; Subhash C Verma; Qiliang Cai; Sabyasachi Haldar; Rajeev Kaul; Mariusz A Wasik; Jaap Middeldorp; Erle S Robertson
Journal:  Virology       Date:  2010-11-19       Impact factor: 3.616

2.  Recent Insights into HIV Accessory Proteins.

Authors:  Jenny L. Anderson; Thomas J. Hope
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.725

3.  Targeting X-linked inhibitor of apoptosis protein inhibits pancreatic cancer cell growth through p-Akt depletion.

Authors:  Chun Jiang; Xiao-Ping Yi; Hong Shen; Yi-Xiong Li
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

Review 4.  Nuclear or cytoplasmic expression of survivin: what is the significance?

Authors:  Fengzhi Li; Jie Yang; Nithya Ramnath; Milind M Javle; Dongfeng Tan
Journal:  Int J Cancer       Date:  2005-04-20       Impact factor: 7.396

5.  Induction of cell cycle arrest by human T-cell lymphotropic virus type 1 Tax in hematopoietic progenitor (CD34+) cells: modulation of p21cip1/waf1 and p27kip1 expression.

Authors:  Adam Tripp; Prabal Banerjee; Michelle Sieburg; Vicente Planelles; Fengzhi Li; Gerold Feuer
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 6.  Human immunodeficiency virus viral protein R as an extracellular protein in neuropathogenesis.

Authors:  Adriano Ferrucci; Michael R Nonnemacher; Brian Wigdahl
Journal:  Adv Virus Res       Date:  2011       Impact factor: 9.937

7.  Apoptosis in murine norovirus-infected RAW264.7 cells is associated with downregulation of survivin.

Authors:  Karin Bok; Victor G Prikhodko; Kim Y Green; Stanislav V Sosnovtsev
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 Vpr induces cell cycle G2 arrest through Srk1/MK2-mediated phosphorylation of Cdc25.

Authors:  Sylvain Huard; Robert T Elder; Dong Liang; Ge Li; Richard Y Zhao
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

9.  The inhibition of the apoptosis pathway by the Coxiella burnetii effector protein CaeA requires the EK repetition motif, but is independent of survivin.

Authors:  Stephanie Bisle; Leonie Klingenbeck; Vítor Borges; Katharina Sobotta; Jan Schulze-Luehrmann; Christian Menge; Carsten Heydel; João Paulo Gomes; Anja Lührmann
Journal:  Virulence       Date:  2016-01-13       Impact factor: 5.882

10.  The HIV-1 protein Vpr targets the endoribonuclease Dicer for proteasomal degradation to boost macrophage infection.

Authors:  Laurieann Casey Klockow; Hamayun J Sharifi; Xiaoyun Wen; Meg Flagg; Andrea K M Furuya; Michael Nekorchuk; Carlos M C de Noronha
Journal:  Virology       Date:  2013-07-09       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.